Samjin Pharmaceuticals Co., Ltd. (KRX:005500)
South Korea
· Delayed Price · Currency is KRW 20,950
+200 (0.96%)
At close: Dec 5, 2025
Samjin Pharmaceuticals Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2022 | FY 2021 | FY 2012 | FY 2011 | FY 2010 | 2009 - 2005 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 4, 2025 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '12 Dec 31, 2012 | Dec '11 Dec 31, 2011 | Dec '10 Dec 31, 2010 | 2009 - 2005 |
| Market Capitalization | 256,800 | 344,067 | 327,511 | 140,529 | 104,902 | 150,669 | Upgrade
|
| Market Cap Growth | 11.68% | 5.05% | 133.05% | 33.96% | -30.38% | -5.60% | Upgrade
|
| Enterprise Value | - | 389,035 | 372,478 | 160,616 | 157,311 | 189,264 | Upgrade
|
| Last Close Price | 20950.00 | 23678.19 | 23536.91 | 7544.50 | 5471.66 | 7633.05 | Upgrade
|
| PE Ratio | 12.13 | 15.72 | 11.53 | 13.21 | 14.85 | 14.38 | Upgrade
|
| PS Ratio | 0.94 | 1.26 | 1.31 | 0.76 | 0.52 | 0.75 | Upgrade
|
| PB Ratio | 0.93 | 1.25 | 1.40 | 1.25 | 0.88 | 1.26 | Upgrade
|
| P/TBV Ratio | 0.97 | 1.30 | 1.46 | 1.27 | 0.89 | 1.28 | Upgrade
|
| P/FCF Ratio | - | - | - | 6.60 | 79.58 | 11.66 | Upgrade
|
| P/OCF Ratio | 14.85 | 19.90 | 13.67 | 4.14 | 8.28 | 8.95 | Upgrade
|
| EV/Sales Ratio | - | 1.42 | 1.49 | 0.87 | 0.78 | 0.94 | Upgrade
|
| EV/EBITDA Ratio | - | 11.79 | 9.03 | 7.51 | 5.79 | 7.58 | Upgrade
|
| EV/EBIT Ratio | - | 16.78 | 10.98 | 9.28 | 6.58 | 8.57 | Upgrade
|
| EV/FCF Ratio | - | - | - | 7.55 | 119.33 | 14.65 | Upgrade
|
| Debt / Equity Ratio | 0.32 | 0.32 | 0.23 | 0.38 | 0.35 | 0.34 | Upgrade
|
| Debt / EBITDA Ratio | 2.65 | 2.65 | 1.32 | 2.01 | 1.53 | 1.64 | Upgrade
|
| Debt / FCF Ratio | - | - | - | 2.02 | 31.44 | 3.17 | Upgrade
|
| Asset Turnover | 0.74 | 0.74 | - | 0.90 | 1.01 | 1.06 | Upgrade
|
| Inventory Turnover | 2.26 | 2.26 | - | 3.09 | 3.26 | 3.32 | Upgrade
|
| Quick Ratio | 0.79 | 0.79 | 1.40 | 1.51 | 1.74 | 2.12 | Upgrade
|
| Current Ratio | 1.64 | 1.64 | 2.83 | 1.89 | 2.09 | 2.60 | Upgrade
|
| Return on Equity (ROE) | 8.59% | 8.59% | - | 9.15% | 5.90% | 9.14% | Upgrade
|
| Return on Assets (ROA) | 3.92% | 3.92% | - | 5.25% | 7.48% | 7.29% | Upgrade
|
| Return on Capital (ROIC) | 4.45% | 4.45% | - | 6.83% | 9.28% | 8.53% | Upgrade
|
| Return on Capital Employed (ROCE) | 7.10% | 7.10% | 12.00% | 13.00% | 17.30% | 16.10% | Upgrade
|
| Earnings Yield | 8.53% | 6.36% | 8.67% | 7.57% | 6.73% | 6.95% | Upgrade
|
| FCF Yield | -7.03% | -5.25% | -14.83% | 15.14% | 1.26% | 8.58% | Upgrade
|
| Dividend Yield | 3.82% | 3.38% | 3.40% | - | - | 0.66% | Upgrade
|
| Payout Ratio | 44.95% | 44.95% | 34.65% | 26.91% | 9.07% | 3.56% | Upgrade
|
| Buyback Yield / Dilution | 2.00% | -3.00% | 5.52% | 0.07% | 1.42% | 0.02% | Upgrade
|
| Total Shareholder Return | 5.82% | 0.38% | 8.92% | 0.07% | 1.42% | 0.67% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.